Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Osteitis Deformans × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 108 Carcinoma, Non-Small-Cell Lung 102 Ovarian Neoplasms 64 Fallopian Tube Neoplasms 36 Lung Neoplasms 28 Carcinoma, Ovarian Epithelial 24 Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Endometrial Neoplasms 22 Uterine Cervical Neoplasms 21 Neoplasms 19 Esophageal Neoplasms 18 Triple Negative Breast Neoplasms 16 Neoplasm Metastasis 16 Stomach Neoplasms 15 Esophageal Squamous Cell Carcinoma 13 Carcinoma 11 Recurrence 10 Brenner Tumor 9 Urinary Bladder Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Head and Neck Neoplasms 7 Adenocarcinoma of Lung 6 Peritoneal Neoplasms 5 Adenocarcinoma 5 Inflammatory Breast Neoplasms 4 Adenocarcinoma Of Esophagus 4 Urethral Neoplasms 3 Thoracic Neoplasms 3 Respiratory Tract Neoplasms 3 Neurotoxicity Syndromes 3

Interventions

ribociclib 1 Trastuzumab 1 Paclitaxel 1 Letrozole 1 Lapatinib 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00553358 2021-09-21

Neo ALTTO

Novartis

Phase 3 Completed

455 enrolled 34 charts

Breast Neoplasms, Osteitis Deformans

Data powered by HemOnc (CC BY 4.0) Colophon ⚡